SCHEMBL13685065

SCHEMBL13685065

CC(C)(C)OC(=O)N[C@@H]1C(=O)N2CC3[C@@H]([C@H]2C(=O)N[C@H](C(=O)C(N)=O)CCCCCCCCCC1(C)C)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13685771 1.00 — —
SCHEMBL8291427 1.00 — —
SCHEMBL16349736 0.94 NAAA (0.30) —
SCHEMBL16349817 0.94 NAAA (0.30) —
SCHEMBL16349807 0.90 — —
SCHEMBL13685219 0.90 — —
SCHEMBL13685318 0.88 F2 (0.34) —
SCHEMBL8290298 0.88 F2 (0.34) —
SCHEMBL7858719 0.88 F2 (0.34) —
SCHEMBL13685052 0.88 F2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
Send feedback